Drug Type Bispecific antibody |
Synonyms DB 003, DB-003 |
Target |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Dotbio Pte Ltd.Startup |
Active Organization Dotbio Pte Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | SG | Dotbio Pte Ltd.Startup | - |